Intermittent Hypoxia Up-Regulates CCL2, RETN, and TNFα mRNAs in Adipocytes via Down-regulation of miR-452

Int J Mol Sci. 2019 Apr 22;20(8):1960. doi: 10.3390/ijms20081960.

Abstract

Sleep apnea syndrome (SAS), characterized by recurrent episodes of oxygen desaturation and reoxygenation (intermittent hypoxia [IH]), is a risk factor for insulin resistance. Recently, IH is considered to independently cause adipose tissue inflammation/dysfunction, leading to worsening insulin resistance; however, the detailed mechanism remains unknown. We exposed mouse 3T3-L1 and human SW872 adipocytes to experimental IH or normoxia for 24 h, and analyzed mRNA expression of several adipokines. We found that the mRNA levels of RETN, TNFα, and CCL2 in SW872 and 3T3-L1 adipocytes were significantly increased by IH, whereas the promoter activities of these genes were not increased. A target mRNA search of microRNA (miR)s revealed that all human mRNAs have a potential target sequence for miR-452. The miR-452 level of IH-treated cells was significantly decreased compared to normoxia-treated cells. MiR-452 mimic and non-specific control RNA (miR-452 mimic NC) were introduced into SW872 cells, and the IH-induced up-regulation of the genes was abolished by introduction of the miR-452 mimic but not by the miR-452 mimic NC. These results indicate that IH stress down-regulates the miR-452 in adipocytes, resulting in increased levels of RETN, TNFα, and CCL2 mRNAs, leading to insulin resistance in SAS patients.

Keywords: adipokine; intermittent hypoxia; microRNA; sleep apnea syndrome.

MeSH terms

  • Adipocytes / metabolism*
  • Animals
  • Cell Hypoxia / genetics
  • Cell Line, Tumor
  • Chemokine CCL2 / genetics*
  • Chemokine CCL2 / metabolism
  • Gene Expression Regulation*
  • Humans
  • Mice
  • MicroRNAs / genetics*
  • Promoter Regions, Genetic
  • RNA Interference*
  • Resistin / genetics*
  • Resistin / metabolism
  • Sleep Apnea, Obstructive / genetics
  • Sleep Apnea, Obstructive / metabolism
  • Transcriptional Activation
  • Tumor Necrosis Factor-alpha / genetics*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • CCL2 protein, human
  • Chemokine CCL2
  • MIRN452 microRNA, human
  • MicroRNAs
  • RETN protein, human
  • Resistin
  • Tumor Necrosis Factor-alpha